Advertisement

SXTC

China SXT Pharmaceuticals, Inc.

Healthcare · USD

Set alert

Price alert · SXTC

All alert types
3.25 USD -0.30 -8.45%
As of Oct 30, 2026 Extended hours 3.15 -3.08%
Bid
3.20 × 1
Ask
3.30 × 1
3.08 Day range 3.50
3.25 52-week range 2,400,000.00
YTD
-100.00%
1 year
-100.00%
Open
3.35
Prev close
3.55
Mkt cap
336.62K
Vol
108.67K
Avg vol
222.67K
EPS
-73,040.00
P/E
0.00
Div yield
0.00%
More statistics
Low
3.08
High
3.50
Forward P/E
0.00
Beta
1.16
Short ratio
0.52
Inst. own
1.35%
Dividend
0.00
Ex-div date
50-d avg
0.47092
200-d avg
0.939895
1y target
0.00

5D chart

Chart tools
Interval
SXTC five-day price chart3.083.373.663.944.23Oct 26Oct 27Oct 28Oct 29Oct 30

Key statistics

Market cap
1.41M
Enterprise value
-7.26M
Trailing P/E
0.00
Forward P/E
0.00
PEG ratio
0.00
Price / sales
0.73
Price / book
0.06
EPS (TTM)
-3.57
Beta
1.16
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-160.67%
Revenue (TTM)
1.93M
Revenue growth
29.50%
Free cash flow
-1.22M
Total cash
12.07M
Total debt
3.70M
Return on equity
-21.65%
Shares outstanding
4.06M
Short % of float
1.84%
50-day average
0.47092
200-day average
0.939895

Analyst view

Consensus: none

Price target (mean) 0.00

Next earnings

Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
SXTC Revenue — annual 41
2017-FY 20172018-FY 20182019-FY 20192020-FY 20202021-FY 20212022-FY 20222023-FY 20232024-FY 20242025-FY 20252026-FY 2026
SXTC Net income — annual -6.21M
2017-FY 20172018-FY 20182019-FY 20192020-FY 20202021-FY 20212022-FY 20222023-FY 20232024-FY 20242025-FY 20252026-FY 2026
SXTC EPS — annual -73,040.00
2017-FY 20172018-FY 20182019-FY 20192020-FY 20202021-FY 20212022-FY 20222023-FY 20232024-FY 20242025-FY 20252026-FY 2026

About China SXT Pharmaceuticals, Inc.

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company had an end-customer base of pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Taizhou, China.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
China
Website
sxtchina.com

News

Your note

Sign in to keep a note on SXTC — it syncs with the Stock Master app.

Institution ownership

SXTC institution ownership
Holder% heldSharesValueReported
Baader Bank Aktiengesellschaft0.37%15,1615.26KSep 29, 2024
Gsa Capital Partners Llp0.30%12,3004.26KSep 29, 2024
Bank of Montreal /CAN/0.25%10,0003.47KSep 29, 2024
UBS Group AG0.21%8,6783.01KSep 29, 2024
JP Morgan Chase & Company0.01%376130Sep 29, 2024
Acadian Asset Management. LLC0.01%379131Sep 29, 2024

Fund ownership

SXTC fund ownership
Holder% heldSharesValueReported
Fidelity NASDAQ Composite Index Fund0.00%5418Oct 30, 2023
Advertisement